Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
21.45
-0.04 (-0.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.09 billion as of December 20, 2024. Its market cap has increased by 19.20% in one year.
Market Cap
3.09B
Enterprise Value
1.86B
1-Year Change
19.20%
Ranking
Category
Stock Price
$21.45
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.09B, an increase of 63.59%. That is a compound annual growth rate of 7.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovoCure | 3.33B |
| MoonLake Immunotherapeutics | 3.29B |
| Inari Medical | 3.25B |
| Envista Holdings | 3.22B |
| Veracyte | 3.17B |
| Warby Parker | 3.03B |
| QuidelOrtho | 3.02B |
| BrightSpring Health Services | 3.01B |